MARKET

XBI

XBI

SPDR® S&P Biotech ETF
NYSEARCA
99.25
+1.91
+1.96%
Opening 09:53 02/27 EST
OPEN
99.81
PREV CLOSE
97.34
HIGH
100.98
LOW
98.88
VOLUME
3.54M
TURNOVER
0
52 WEEK HIGH
100.98
52 WEEK LOW
63.80
TOTAL ASSET
7.52B
YTD YIELD
19.41%
1D
5D
1M
3M
1Y
5Y
Author Larry McDonald’s short-term high convection list
Author Larry McDonald’s short-term high convection list should offer gains in the next 30 to 60 days. New York Times bestselling author and CNBC contributor Larry McDonald added Nike Inc. (NKE) to the list in an issue of The Bear Traps Report.
Seeking Alpha · 1d ago
Look Under The Hood: XBI Has 44% Upside
NASDAQ · 1d ago
Weekly Report: what happened at XBI last week (0219-0223)?
Weekly Report · 1d ago
Is SPDR S&P Biotech ETF (XBI) a Strong ETF Right Now?
NASDAQ · 5d ago
Healthcare dealmakers see increased M&A, valuations in 2024: KPMG
Healthcare dealmakers see increased M&A, valuations in 2024: KPMG. 61% of respondents are expecting more deals in 2024. M&a in the life sciences and healthcare sectors has dropped substantially since 2021. Inflation and rising rates are expected to impact deal activity this year.
Seeking Alpha · 02/19 20:48
Weekly Report: what happened at XBI last week (0212-0216)?
Weekly Report · 02/19 10:41
Top 10 ETFs have the lowest weighted average free cash flow yield - GS
Top 10 ETFs have the lowest weighted average free cash flow yield - GS. Goldman Sachs recommended hedging three-month puts on ETFs in sectors with low free cash cash flow. Biotechnology and semis ETFs has the lowest average FCFY, the report showed.
Seeking Alpha · 02/15 21:42
Implied XBI Analyst Target Price: $136
NASDAQ · 02/15 12:56
More
Profile
Fund Name
SPDR® S&P Biotech ETF
Inception Date
2006-01-31
Benchmark
S&P Biotechnology Select Industry TR USD
Advisor Company
SSgA Funds Management Inc
Custodian
State Street Bank and Trust Co
Manager
Michael Feehily, Raymond Donofrio, Karl Schneider